Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.

International journal of molecular sciences - 22 Jun 2024

Andrzejczak Anna, Małkiewicz Bartosz, Tupikowski Krzysztof, Ptaszkowski Kuba, Szydełko Tomasz, Karabon Lidia

Abstract excerpt

Renal cell carcinoma (RCC) accounts for approximately 90-95% of all kidney cancers in adults, with clear cell RCC (ccRCC) being the most frequently identified subtype. RCC is known for its responsiveness to immunotherapy, making it an area of significant research interest. Immune checkpoint (IC) molecules, which regulate immune surveillance, are established therapeutic targets in RCC. The aim of this study was to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, CD

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to Case-Control Studies

Share to GPI-Linked Proteins

Share to Kidney Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Receptors, Immunologic

Source

Open in PubMed Open full text

Identifiers

PMID: 38999968
DOI: 10.3390/ijms25136860
PMCID: PMC11241222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival.PMID 38999968Read ↗

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall SurvivalSemantic proximity Read ↗

Polymorphisms in the Von Hippel-Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors.Semantic proximity Read ↗

Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaSemantic proximity Read ↗

Association of KIM-1 (HAVCR1) Expression with the Tumor Immune Microenvironment in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma.Semantic proximity Read ↗

8q24 Clear Cell Renal Cell Carcinoma Germline Variant is Associated with VHL Mutation Status and Clinical AggressivenessSemantic proximity Read ↗

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.Semantic proximity Read ↗

Does the VHL polymorphisms rs779805 and rs1642742 affect renal cell carcinoma susceptibility, prognosis and survival in Central European population?Semantic proximity Read ↗

Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.Semantic proximity Read ↗

Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

VHL and HIF-1α: gene variations and prognosis in early-stage clear cell renal cell carcinoma.Semantic proximity Read ↗

Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.